This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Exelixis, Inc.. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: Anindita Chakrabarty: Innovator in Cancer Treatment
Introduction
Anindita Chakrabarty is a prominent inventor based in Nashville, TN (US). She has made significant contributions to the field of cancer treatment through her innovative research and development of therapeutic methods.
Latest Patents
Anindita holds a patent for "Combinations of kinase inhibitors for the treatment of cancer." This invention provides methods of treating cancer by administering a compound of formula I, optionally as a pharmaceutically acceptable salt, solvate, and/or hydrate thereof, in combination with an inhibitor that targets HER2 and/or HER3. This groundbreaking work has the potential to improve treatment outcomes for cancer patients.
Career Highlights
Throughout her career, Anindita has worked with notable companies such as Exelixis, Inc. and Sanofi. Her experience in these organizations has allowed her to collaborate with leading experts in the field and contribute to advancements in cancer therapies.
Collaborations
Anindita has collaborated with esteemed colleagues, including Dana T Aftab and Carlos L Arteaga. These partnerships have further enriched her research and development efforts in the medical field.
Conclusion
Anindita Chakrabarty is a trailblazer in the realm of cancer treatment innovations. Her dedication to improving patient care through her patented inventions exemplifies her commitment to advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile